Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Combined flu and Covid vaccine from Moderna shows positive results
dpa international via Yahoo News· 3 days agoThe results raise hopes the new vaccine could be approved by regulators this year, with the...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 4 hours agoPer Zambrano, all three COVID vaccine manufacturers—Pfizer, Moderna, and Novavax—have said that...
Combined mRNA COVID-flu vaccine shows promise in Moderna trial
Semafor via Yahoo News· 2 days ago“You’re getting one dose, one needle versus two needles,” Moderna CEO Stéphane Bancel told the BBC...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 6 days agoVaccine manufacturers, including Pfizer, Moderna, and Novavax, have already been working on a JN.1 ...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 3 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 3 days agoThere could be a combined Covid-19 and flu shot in our future, although it won’t be ready for this...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 7 days agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...